What counter-ion should I expect on an SWB orforglipron lot?

What I am working with: SWB · orforglipron.

I can parse the result. I am less sure what it licenses me to conclude.

I have deliberately not looked at anyone else’s interpretation yet.

What is the correct interpretation, and what is the common misreading?

The short version: peptides are supplied as salts, the salt is real mass, and neither purity nor a chromatogram will tell you how much of it there is.

Peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.

Specifically, trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.

Counter-ion content scales with the number of basic residues, following directly from charge balance.

Absence of a counter-ion figure is an absent measurement rather than a low one.

Purity says nothing about counter-ion. They are unrelated measurements.

Start with which counter-ion the process produced, because trifluoroacetate from reverse-phase purification and acetate from a salt exchange behave differently and are quantified differently.

Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.

Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.

Ion chromatography and fluorine NMR are the accepted quantitative methods for trifluoroacetate, and neither is a chromatographic purity method.

Count the basic residues and you can estimate the counter-ion load.

The relevant arithmetic is that gross mass equals peptide plus counter-ion plus water, and the certificate usually reports only the first indirectly.

Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.

Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.

Water plus counter-ion is why gross mass and peptide mass differ.

A net-peptide-content figure already accounts for it, which is why net content is the number worth asking for.

The number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.

The ICH Q3A and Q3B thresholds for reporting, identification and qualification of impurities are the framework the pharmaceutical industry works to, and they are worth reading even though nothing in the research-grade supply chain is obliged to meet them, because they tell you which numbers a competent analyst would consider worth reporting at all.

Net peptide content varies between lots as the process varies, so one figure does not characterise a supplier.

Trifluoroacetate unless a deliberate exchange was done. Ask which.

edited 21 Mar 2025 by rota_site — tightened the wording; no substantive change